Probabilistic learning to perform pre-onset individualised prediction of disease severity: application to Veno Occlusive Disease
arXiv:2606.06516v1 Announce Type: cross Abstract: We advance a new probabilistic supervised learning approach that permits reliable, automated, and early individualised prediction of the severity with which a disease will develop in a prospective patient. The prediction capacity is illustrated via the pre-transplant prediction of the score of severity of Veno Occlusive Disease (or VOD) in the digital twin (DT) of the considered prospective patient, where this score parametrises the severity with which VOD will develop in this patient, after they undergo their Bone Marrow Transplant. The learni
The continuous advancements in probabilistic learning and computational power enable the development of sophisticated predictive models for complex biological systems, making such applications increasingly feasible.
This development represents a significant step towards personalized medicine, offering early and individualized disease severity predictions that can fundamentally alter treatment pathways and patient outcomes.
The ability to predict disease severity pre-onset using digital twins shifts medical practice from reactive treatment to proactive, personalized intervention strategies, particularly in high-risk procedures like bone marrow transplants.
- · Healthcare providers
- · Patients with high-risk conditions
- · AI in medical diagnostics
- · Pharmaceutical research and development
- · Traditional, one-size-fits-all medical treatment approaches
Individualized treatment plans can be adopted based on predicted disease severity, improving patient prognoses.
The demand for digital twin technology and advanced AI in healthcare will accelerate, spurring innovation and investment in these areas.
Ethical and regulatory frameworks around predictive AI in medicine will need to evolve rapidly to ensure equitable access and responsible use of these powerful tools.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG